A 20-year cohort analysis of medical records in the UK revealed that blood pressure (BP) decreased for more than a decade before death in patients dying at 60 years and older. The analysis included 46 634 participants dying aged at least 60 years (51.7% female; mean age at death 82.4 years), from 2010 to 2014; and compared BP slopes from 10 to 3 years before death for 20 207 participants who died, with 20 207 birth-year and sex-matched participants surviving longer than 9 years. Systolic BP (SBP) and diastolic BP (DBP) peaked 18 to 14 years before death and then decreased progressively. Mean changes in SBP from peak values ranged from −8.5 mm Hg for those dying aged 60 to 69 years to −22.0 mm Hg for those dying at 90 years or older; overall, 64.0% of individuals had SBP changes of greater than −10 mm Hg. Decreases in BP appeared linear from 10 to 3 years before death, with steeper decreases in the last 2 years of life. Decreases in SBP from 10 to 3 years before death were present in individuals not treated with antihypertensive medications, but mean yearly changes were steepest in patients with hypertension (−1.58 vs −0.70 mm Hg), dementia (−1.81 vs −1.41 mm Hg), heart failure (−1.66 vs −1.37 mm Hg), and late-life weight loss. Another population-based study of 303 patients who underwent autopsy in the US found that those with microinfarcts did not differ on baseline BP compared with those with no microinfarcts; however, participants with subcortical microinfarcts had a greater annual decline of BP. The presence of microinfarcts is associated with cognitive decline. Source: https://jamanetwork.com/
A study revealed that stroke remains a major global health challenge, influenced by numerous risk…
A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…
A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…
A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…
A Canadian study of adults with high blood pressure (BP) found no difference in health…
Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…
This website uses cookies.